• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Stem Cells in Ovarian Cancer and Potential Therapies.

作者信息

Zuber Elena, Schweitzer Diana, Allen Dominick, Parte Seema, Kakar Sham S

机构信息

Department of Physiology, University of Louisville, Louisville, KY40202.

Department of Biochemistry and Molecular Biology, University of Nebraska, Omaha, NE-68198-5870.

出版信息

Proc Stem Cell Res Oncog. 2020 May;8. Epub 2020 May 3.

PMID:32776013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7413600/
Abstract
摘要

相似文献

1
Stem Cells in Ovarian Cancer and Potential Therapies.卵巢癌中的干细胞及潜在治疗方法。
Proc Stem Cell Res Oncog. 2020 May;8. Epub 2020 May 3.
2
Ovarian cancer stem cells and their role in drug resistance.卵巢癌细胞及其在耐药性中的作用。
Int J Biochem Cell Biol. 2019 Jan;106:117-126. doi: 10.1016/j.biocel.2018.11.012. Epub 2018 Nov 30.
3
Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer.针对上皮-间质转化和癌干细胞治疗化疗耐药性卵巢癌
Oncotarget. 2016 Aug 23;7(34):55771-55788. doi: 10.18632/oncotarget.9908.
4
Integrative analysis of the common genetic characteristics in ovarian cancer stem cells sorted by multiple approaches.通过多种方法分选的卵巢癌细胞干细胞的常见遗传特征的综合分析。
J Ovarian Res. 2020 Sep 25;13(1):116. doi: 10.1186/s13048-020-00715-7.
5
Cancer Stem Cells in Ovarian Cancer-A Source of Tumor Success and a Challenging Target for Novel Therapies.卵巢癌中的癌症干细胞——肿瘤成功的根源和新型治疗的挑战性靶点。
Int J Mol Sci. 2022 Feb 24;23(5):2496. doi: 10.3390/ijms23052496.
6
Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype.卵巢癌可塑性与获得干细胞样表型过程中的表观基因组学
J Ovarian Res. 2008 Nov 24;1:8. doi: 10.1186/1757-2215-1-8.
7
The significance of the pluripotency and cancer stem cell-related marker NANOG in diagnosis and treatment of ovarian carcinoma.多能性及癌症干细胞相关标志物NANOG在卵巢癌诊断与治疗中的意义
Eur J Gynaecol Oncol. 2016;37(5):604-612.
8
Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer.靶向肿瘤干细胞克服卵巢癌的治疗抵抗。
Cells. 2020 Jun 4;9(6):1402. doi: 10.3390/cells9061402.
9
Ovarian cancer stem cells: elusive targets for chemotherapy.卵巢癌干细胞：化疗的难以捉摸的靶点。
Med Oncol. 2012 Dec;29(5):3400-8. doi: 10.1007/s12032-012-0252-6. Epub 2012 May 26.
10
Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets.卵巢癌干细胞：分子概念及其作为治疗靶点的相关性。
Mol Aspects Med. 2014 Oct;39:110-25. doi: 10.1016/j.mam.2013.06.002. Epub 2013 Jun 25.

引用本文的文献

1
The Role of Cancer Stem Cell Markers in Ovarian Cancer.癌症干细胞标志物在卵巢癌中的作用
Cancers (Basel). 2023 Dec 20;16(1):40. doi: 10.3390/cancers16010040.
2
Mast Cells Retard Tumor Growth in Ovarian Cancer: Insights from a Mouse Model.肥大细胞延缓卵巢癌肿瘤生长：来自小鼠模型的见解
Cancers (Basel). 2023 Aug 26;15(17):4278. doi: 10.3390/cancers15174278.
3
Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies.妇科癌症、癌症干细胞及可能的靶向治疗

本文引用的文献

1
The American Cancer Society's Facts & Figures: 2020 Edition.美国癌症协会《2020年事实与数据》版
J Adv Pract Oncol. 2020 Mar;11(2):135-136. doi: 10.6004/jadpro.2020.11.2.1. Epub 2020 Mar 1.
2
Targeting cancer stem cell pathways for cancer therapy.针对癌症干细胞通路的癌症治疗。
Signal Transduct Target Ther. 2020 Feb 7;5(1):8. doi: 10.1038/s41392-020-0110-5.
3
Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods.卵巢癌、癌症干细胞和当前治疗策略：Magmas 在当前治疗方法中的潜在作用。
Front Pharmacol. 2022 Feb 16;13:823572. doi: 10.3389/fphar.2022.823572. eCollection 2022.
4
Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer.描述上皮性卵巢癌的内分泌状态、肿瘤缺氧和免疫原性，以预测治疗效果。
Front Endocrinol (Lausanne). 2021 Nov 17;12:772349. doi: 10.3389/fendo.2021.772349. eCollection 2021.
5
Ovarian Cancer Stem Cells: Characterization and Role in Tumorigenesis.卵巢癌干细胞：特征与在肿瘤发生中的作用。
Adv Exp Med Biol. 2021;1330:151-169. doi: 10.1007/978-3-030-73359-9_10.
Cells. 2020 Mar 14;9(3):719. doi: 10.3390/cells9030719.
4
Precision Medicine Tumor Boards: Clinical Applicability of Personalized Treatment Concepts in Ovarian Cancer.精准医学肿瘤多学科讨论会议：个性化治疗理念在卵巢癌中的临床适用性
Cancers (Basel). 2020 Feb 27;12(3):548. doi: 10.3390/cancers12030548.
5
Self-Renewal Signalling Pathway Inhibitors: Perspectives on Therapeutic Approaches for Cancer Stem Cells.自我更新信号通路抑制剂：癌症干细胞治疗方法的前景
Onco Targets Ther. 2020 Jan 16;13:525-540. doi: 10.2147/OTT.S224465. eCollection 2020.
6
Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition.JAK/STAT3信号通路在上皮-间质转化调控肿瘤转移、癌症干细胞转变及肿瘤化疗耐药中的作用
Cells. 2020 Jan 15;9(1):217. doi: 10.3390/cells9010217.
7
Cancer statistics, 2020.癌症统计数据，2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
8
Ovarian cancer stem cells and targeted therapy.卵巢癌干细胞与靶向治疗。
J Ovarian Res. 2019 Dec 6;12(1):120. doi: 10.1186/s13048-019-0588-z.
9
The Potential of PI3K/AKT/mTOR Signaling as a Druggable Target for Endometrial and Ovarian Carcinomas.PI3K/AKT/mTOR 信号通路作为子宫内膜癌和卵巢癌的潜在可用药靶。
Curr Drug Targets. 2020;21(10):946-961. doi: 10.2174/1389450120666191120123612.
10
Targeting YAP suppresses ovarian cancer progression through regulation of the PI3K/Akt/mTOR pathway.靶向 YAP 通过调控 PI3K/Akt/mTOR 通路抑制卵巢癌细胞的进展。
Oncol Rep. 2019 Dec;42(6):2768-2776. doi: 10.3892/or.2019.7370. Epub 2019 Oct 14.